《Acute kidney injury among salicylate intoxication hospitalisations in the United States》 was written by Thongprayoon, Charat; Petnak, Tananchai; Kaewput, Wisit; Qureshi, Fawad; Mao, Michael A.; Pivovarova, Aleksandra I.; Boonpheng, Boonphiphop; Bathini, Tarun; Vallabhajosyula, Saraschandra; Medaura, Juan; Cheungpasitporn, Wisit. Name: Methyl Salicylate And the article was included in International Journal of Clinical Practice in 2021. The article conveys some information:
This study aimed to evaluate the risk factors and the association of acute kidney injury (AKI) with outcomes, and resource utilization in patients hospitalised because of salicylate intoxication in the United States. Hospitalised patients with a primary diagnosis of salicylate intoxication from 2003 to 2014 were identified in the National Inpatient Sample (NIS) database. End-stage kidney disease patients were excluded. The occurrence of AKI was identified using hospital diagnosis code. Clin. characteristics, in-hospital treatment, outcomes and resource utilization were compared between patients with and without AKI. A total of 13 787 eligible hospital admissions were included in the anal. AKI occurred in 1279 (9.3%) admissions. Older age, male sex, more recent year of hospitalisation, anemia, hypertension, congestive heart failure, chronic kidney disease, volume depletion, sepsis and ventricular arrhythmia/cardiac arrest were significantly associated with increased risk of AKI, whereas Hispanic race was associated with decreased risk. AKI was significantly associated with increased risk of organ failure, and in-hospital mortality. In addition, the need for ventilation support, blood component transfusion, renal replacement therapy, length of hospital stay and hospitalisation cost were higher in AKI patients. Approx. one tenth of salicylate intoxication patients developed AKI during hospitalisation. AKI was associated with higher morbidity, mortality and resource utilizations. In the part of experimental materials, we found many familiar compounds, such as Methyl Salicylate(cas: 119-36-8Name: Methyl Salicylate)
Methyl Salicylate(cas: 119-36-8) has been used: as a component of clarifying solution for treating Mongolian gerbil cochlea intact for immunofluorescence analysis, as a plant elicitor to test its effect on reducing the whitefly population from tomato plants.Name: Methyl Salicylate
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics